the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
Clinical trial NCT07338851 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07338851
- Sponsor
- China National Biotec Group Company Limited
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-30
- Primary completion
- 2026-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.